Skip to main content

What is Nucala (mepolizumab) used for and how is it given?

Medically reviewed by Kristianne Hannemann, PharmD. Last updated on March 28, 2025.

Official Answer by Drugs.com

Nucala (mepolizumab) is a biologic therapy used for the treatment of severe eosinophilic asthma, eosinophilic granulomatosis with polyangiitis (EGPA), and hypereosinophilic syndrome (HES). It is given by subcutaneous injection every four weeks. It works as an interleukin-5 (IL-5) antagonist monoclonal antibody, helping to control eosinophil levels and reduce symptoms.

Indications for Nucala:

How is Nucala administered?

Nucala is an injectable medication given by subcutaneous injection (under the skin) every 4 weeks.

Nucala is available as a vial, single-dose prefilled autoinjector, or a single-dose prefilled syringe. The injection may be administered by a health care provider or patient caregiver, or self-administered by patients who are 12 years of age and older.

Injection Sites:

You and your caregiver should be trained on how to prepare and perform your injection before trying to give the injection.

Instructions for Use: Prefilled Autoinjector

1. Prepare Your Injection

2. Choose & Clean Your Injection Site

3. Inject Nucala

4. Dispose of the Autoinjector

Related questions

Instructions for Use: Prefilled Syringe

1. Prepare Your Injection

3. Choose & Clean Your Injection Site

3. Inject Nucala

4. Dispose of the Syringe

Important Notes:

This is not all the information you need to know about Nucala (mepolizumab) for safe and effective use and does not take the place of your doctor’s directions. Review the full product information and discuss this information and any questions you have with your doctor or other health care provider.

References

Nucala [package insert]. Updated March 2023. GlaxoSmithKline LLC. Accessed March 28, 2025 at https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fefb887c-e4ac-431e-8893-e9d1a5a63fea

Read next

How does Nucala (mepolizumab) work? What is the MOA?

Nucala (mepolizumab) works by lowering the activity of white blood cells called eosinophils. Too many eosinophils can sometimes lead to inflammation in the body. Nucala is a monoclonal antibody that blocks a cytokine called interleukin-5 (IL-5). Continue reading

Can Nucala be self-administered? How is it injected?

Yes, Nucala can be self-administered. Nucala is available as a prefilled syringe or autoinjector that can be self-administered after a doctor has shown you how to administer it. 99% of people can successfully self-administer the Nucala prefilled syringe and 89-95% can successfully administer the Nucala autoinjector.

Continue reading

Can severe asthma lead to COPD?

Severe and poorly controlled asthma can lead to damaged lungs which may increase the risk of developing chronic obstructive pulmonary disease (COPD). Symptoms of asthma and COPD may frequently co-exist in smokers and the elderly. Continue reading

See also:

Related medical questions

Drug information

Related support groups